FDA Withdraws Pediatric Data-Submission Rule, But Aims To Regroup Shortly
FDA has 1withdrawn a new regulation that would have required companies to submit additional pediatric patient data as part of pre-market submissions beginning next month, but says it hopes to finalize a possibly revised version soon
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
